C12N 2770/32461
Methods of inactivation or attenuation
C12N2770/32461 (Methods of inactivation or attenuation) appears on 24 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 24
- Published applications
- 6
- Assignees
- 17
- Inventors
- 46
- Latest grant
- 20 Sep 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 0 |
| 2003 | 2 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Method for extracting hepatitis a virus (HAV) antigen from cell culture20 Sep 2022US 11,447,528 B2Mediagnost Gesellschaft für Forschung und Herctellung von Diagnostika GmbH
- Hepatitis A vaccines31 Jan 2006US 6,991,929 B1SmithKline Beecham Biologicals s.a.
- Methods and compositions for the selective modification of nucleic acids9 Sep 2003US 6,617,157 B1V. I. Technologies, Inc.
- Combined vaccine against both HAV and measles virus and method of producing it13 May 2003US 6,562,350 B1Changchun Institute of Biological Products, Ministry of Public Health
- Method for producing non-infectious recombinant picornavirus particles27 Aug 2002US 6,440,718 B1november Aktiengesellschaft Gesellschaft fur Molekulare Medizin
- Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasma24 Oct 2024US 2024/0350691 A1Aphios Corporation
- Method for Extracting Hepatitis A Virus (HAV) Antigen from Cell Culture24 Mar 2022US 2022/0089649 A1Mediagnost Gesellschaft FüR Forschung Und Herstellung Von Diagnostika GmbH
- Growth of wild-type hepatitis a virus in cell culture4 Mar 2010US 2010/0055670 A1Government of the US, as represented by the Secretary, Dept. of Health and Human Services
- Hepatitis A vaccines26 May 2005US 2005/0112144 A1SmithKline Beecham Biologicals s.a.
- Methods and compositions for the selective modification of nucleic acids18 Mar 2004US 2004/0053316 A1V. I. Technologies, Inc.
Most cited
By later US patents
- Process for making novel blood clotting enzyme compositions43US 4,495,278 ABaxter Travenol Laboratories, Inc. · 1985
- Methods and compositions for the selective modification of nucleic acids24US 6,093,564 AV. I. Technologies, Inc. · 2000
- Vaccine against hepatitis A virus23US 4,894,228 AThe United States of America as represented by the Department of Health and Human Services · 1990
- Growth of hepatitus A virus in vero cells18US 4,783,407 AMerck & Co., Inc. · 1988
- Hepatitis A virus purified and triply cloned12US 4,620,978 AThe United States of America as represented by the Department of Health and Human Services · 1986